TITLE

Review: Angiotensin-receptor blockers and angiotensin-converting enzyme inhibitors have the lowest risk for diabetes

AUTHOR(S)
Elliott, W. J.; Meyer, P. M.
PUB. DATE
May 2007
SOURCE
ACP Journal Club;May/Jun2007, Vol. 146 Issue 3, p73
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reviews a study on the relative odds of developing diabetes with the long-term use of various types of antihypertensive drugs by patients with hypertension or other cardiovascular risk factors. The network meta-analysis is used to combine direct and indirect comparison among drug types. Antihypertensive drugs associated with the lower risk for diabetes are angiotensin-receptor blockers and angiotensin-converting enzyme inhibitors. Drugs associated with the highest risks are diuretics.
ACCESSION #
25169123

 

Related Articles

  • Hypertension.  // Current Medical Literature: Cardiology;2007, Vol. 26 Issue 3, p87 

    The article offers information on several studies related to hypertension. It includes "Long Term Effects of Dietary Sodium Reduction on Cardiovascular Disease Outcomes: Observational Follow-Up of the Trias of Hypertension Prevention (TOHP)," by N. R. Cook, "Claims in Advertisements for...

  • Treatment of Prehypertension in Diabetes and Metabolic Syndrome. Segura, Julian; Ruilope, Luis M. // Diabetes Care;Nov2009 Supplement, Vol. 32, pS284 

    The article explores the benefits of treating prehypertension in patients with diabetes and/or metabolic syndrome. It mentions that patients with elevated blood pressure (BP) and metabolic syndrome tend to be at great cardiovascular risk. The European Guidelines recommend antihypertensive...

  • Olmesartan Medoxomil. Grassi, Guido; Mancia, Giuseppe // High Blood Pressure & Cardiovascular Prevention;Mar2010, Vol. 17 Issue 1, p1 

    Inadequate blood pressure (BP) control represents one of the major challenges of antihypertensive treatment, being responsible for the elevated cardiovascular morbidity and mortality associated with hypertension. Although guidelines strongly recommend BP control as a primary therapeutic goal,...

  • Should White-Coat Hypertension in Diabetes Be Treated? Pro. Mancia, Giuseppe; Sega, Roberto; Bombelli, Michele; Quarti-Trevano, Fosca; Facchetti, Rita; Grassi, Guido // Diabetes Care;Nov2009 Supplement, Vol. 32, pS305 

    The article examines the rationality of treating white coat hypertension in diabetes. White coat hypertension refers to a condition in which clinic blood pressure repeatedly registers ≥140 millimeters of mercury (mmHg) systolic or 90 mmHg diastolic. The link between white coat hypertension...

  • UK doctors slow to utilize combination therapy for hypertension.  // PharmaWatch: Monthly Review;Jan2005, Vol. 4 Issue 1, p15 

    The article reports on the failure of doctors in Great Britain to fully recognize the therapeutic benefits of combined treatment approach in treating hypertension. Research studies showed that majority of hypertension sufferers are not fully controlled on a single antihypertensive therapy. Many...

  • Hora de elegir. Toledo, Rafael Bravo // AMF: Actualización en Medicina de Familia;2010, Vol. 6 Issue 7, p415 

    No abstract available.

  • Anti-hypertensive treatment compliance.  // Caribbean Health;Dec2001, Vol. 4 Issue 6, p21 

    The article reports on issues about anti-hypertensive treatment compliance. A study in Basle, Switzerland has suggested that this suspicion may often be unwarranted. The study included 110 patients with hypertension treated with two hypertensive drugs for at least 4 weeks. Treatment compliance...

  • Stable plasma magnesium and potassium status in essential hypertensive patients with normal renal function under therapy with the renin inhibitor aliskiren. Kisters, K.; Gremmler, B.; Nguyen, M. Q.; Tokmak, F. // Trace Elements & Electrolytes;2011 2nd Quarter, Vol. 28 Issue 2, p113 

    Lowered Mg++ stores in humans seem to be involved in the pathogenesis of essential hypertension. However, some antihypertensive drugs (e.g. in particular diuretics) can additionally decrease plasma or intracellular Mg-H- stores. In this context the role of the new antihypertensive renin...

  • Natriuretic and renal hemodynamic effects of nicardipine in essential hypertension. Chaignon, Michel; Bellet, Marc; Lucsko, Michel; Rapoud, Catherine; Guédon, Jacques // Kidney International Supplement;Sep1988, Issue 25, p184 

    Studies the natriuretic and renal hemodynamic effects of oral nicardipine in hypertension. Patients enrolled in the study; Effects of oral nicardipine on sodium excretion and renal hemodynamics; Difference in the effects of nicardipine on sodium excretion from those observed with minoxidil.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics